Giant cell tumor of axial vertebra: surgical experience of five cases and a review of the literature

World Journal of Surgical Oncology

Zhen Wang¹  Zheng Guo¹  Hongbin Fan¹  Xiangdong Li¹  Jing Li¹  Guojing Chen¹ 

[1] Department of Orthopedics, Xijing Hospital, Fourth Military Medical University, Changle Road, Xi’an 710032, People’s Republic of China

关键词: Odontoid process;    Reconstruction;    Intralesional;    Axial vertebra;    Giant cell tumor;   

Others  :  1131021
DOI  :  10.1186/s12957-015-0438-4

 received in 2014-05-27, accepted in 2015-01-05,  发布年份 2015

【 摘 要 】

Background

Due to the complex anatomy of the upper cervical spinal column region and the variable aggressiveness of giant cell tumors (GCTs), there exists no standard treatment for GCTs of axial vertebra. To the best of our knowledge, there are only a few case reports in the literature and no large sum numbers of clinical trials about the treatment of, or research into, axial vertebra GCTs.

Methods

Between 2009 and 2013, five patients pathologically diagnosed with axial vertebra GCTs were treated at our hospital. We performed intralesional excision and odontoid process reconstructive surgery to preserve the odontoid process, followed with adjuvant radiation therapy after surgery.

Results

For those with an intact bone shell, part of the β-TCP (beta tricalcium phosphate) artificial bone could be seen clearly after surgery and became blurred three months after surgery, as seen on a radiograph. One year later, the part of β-TCP artificial bone was fused as a block. Subsequently, autogenous bone regenerated successfully and artificial bone degraded thoroughly. For those with a defective cortical bone, partial fusion of the odontoid process, autograft ilium and third vertebra body could be seen three months after surgery, and complete fusion was seen nine months later. The odontoid process was preserved successfully, and the upper cervical spine was reconstructed effectively, without implant failure or infection.

Conclusions

In this study, the odontoid process and function of upper cervical vertebra was preserved successfully through lesion curettage, combined with reconstruction with bone grafting, and adjuvant radiation therapy after surgery. During the follow-up periods, no recurrence or complications was observed.

【 授权许可】

   
2015 Chen et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 4.

【 参考文献 】

• [1]Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM: Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982, 4:755-61.
• [2]Dahlin DC, Cupps RE, Johnson EWJ: Giant-cell tumor: a study of 195 cases. Cancer. 1970, 25:1061-70.
• [3]Zhang Q, Zhao H, Maheshwari AD, Cai L, Yu F, Niu X: Isolated cardiac metastasis from a histologically “Benign” giant-cell tumor of the distal end of the Femur: a case report. J Bone Joint Surg Am. 2010, 92:2725-31.
• [4]Peh WC, Koh WL, Kwek JW, Htoo MM, Tan PH: Imaging of painful solitary lesions of the sacrum. Australas Radiol. 2007, 51:507-15.
• [5]Petrie A: Statistics in orthopaedic papers. J Bone Joint Surg Br. 2006, 88:1121-36.
• [6]Lorenzo ND, Delfini R, Ciappetta P, Cantore G, Fortuna A: Primary tumors of the cervical spine: surgical experience with 38 cases. Surg Neurol. 1992, 38:12-8.
• [7]Shirakuni T, Tamaki N, Matsumoto S, Fujiwara M: Giant cell tumor in cervical spine. Surg Neurol. 1985, 23:148-52.
• [8]Viswanathan S, Jambhekar NA: Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities? Clin Orthop Relat Res. 2010, 468:827-33.
• [9]Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y: Cryosurgery in the treatment of giant cell tumor: a long-term follow up study. Clin Orthop Relat Res. 1999, 359:176-88.
• [10]Oda Y, Miura H, Tsuneyoshi M, Iwamoto Y: Giant cell tumor of bone: oncological and functional results of long-term follow-up. Jpn J Clin Oncol. 1998, 28:323-8.
• [11]Guo W, Ji T, Tang X, Yang Y: Outcome of conservative surgery for giant cell tumor of the sacrum. Spine. 2009, 34:1025-31.
• [12]Balke M, Streitbuerger A, Budny T, Henrichs M, Gosheger G, Hardes J: Treatment and outcome of giant cell tumors of the pelvis. Acta Orthop. 2009, 80:590-6.
• [13]Leggon RE, Zlotecki R, Reith J, Scarborough MT: Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res. 2004, 423:196-207.
• [14]Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, et al.: Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003, 57:158-65.
• [15]Donati D, Wafa H, Di Bella C, Colangeli M, Colangeli S, Bertoni F: Management of pelvic giant cell tumours involving the acetabular bone. Acta Orthop Belg. 2008, 74:773-8.
• [16]Cai X, He X, Li H, Wang D. Total atlanto-odontoid joint arthroplasty system: a novel motion preservation device for atlantoaxial instability after odontoidectomy. Spine (Phila Pa 1976). 2013;38:E451–7.
• [17]Mori Y, Takayasu M, Saito K, Seki Y, Shibuya M, Yoshida J: Benign osteoblastoma of the odontoid process of the axis: a case report. Surg Neurol. 1998, 49:274-7.
• [18]Campanacci M: Giant cell tumor. In Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. 2nd edition. Edited by Campanacci M, Enneking WF. Springer-Verlag, New York, NY; 1999:99-136.
• [19]Wang Z, Guo Z, Bai H, Li J, Li X, Chen G, et al.: Clinical evaluation of β-TCP in the treatment of lacunar bone defects: a prospective, randomized controlled study. Mater Sci Eng C Mater Biol Appl. 2013, 33:1894-9.
• [20]Fletcher CDM, Unni KK, Mertens F: Pathology and genetics of tumours of soft tissue and bone. International Agency for Research on Cancer Press, Lyon; 2002.
• [21]Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, et al.: Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012, 94:461-7.
• [22]Jeys LM, Suneja R, Chami G, Grimer RJ, Carter SR, Tillman RM: Impending fractures in giant cell tumours of the distal femur: incidence and outcome. Int Orthop. 2006, 30:135-8.
• [23]Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, et al.: Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008, 79:86-93.
• [24]Shen CC, Li H, Shi ZL, Tao HM, Yang ZM: Current treatment of sacral giant cell tumour of bone: a review. J Int Med Res. 2012, 40:415-25.
• [25]Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH: Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011, 469:591-9.
• [26]Yu XC, Xu M, Song RX, Fu ZH, Liu XP: Long-term outcome of giant cell tumors of bone around the knee treated by en bloc resection of tumor and reconstruction with prosthesis. Orthop Surg. 2010, 2:211-7.
• [27]Puthoor DK, Puthezhath K: Management of giant cell tumor of bone: computerized tomography based selection strategy and approaching the lesion through the site of cortical break. Orthop Surg. 2012, 4:76-82.
• [28]Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, et al.: Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010, 36:1-7.
• [29]Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ: Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res. 2005, 435:211-8.
• [30]Turcotte RE: Giant cell tumor of bone. Orthop Clin North Am. 2006, 37:35-51.
• [31]Algawahmed H, Turcotte R, Farrokhyar F, Ghert M: High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma. 2010, 2010:586090.
• [32]Szendröi M: Giant-cell tumour of bone. J Bone Joint Surg Br. 2004, 86:5-12.
• [33]Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donnell RJ: Local control of long bone giant cell tumor using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006, 30:495-8.
• [34]Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jörgensen P, et al. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br. 2006;88:531–5.
• [35]Bosma JJ, Pigott TJ, Pennie BH, Jaffray DC: En bloc removal of the lower lumbarvertebral body for chordoma: report of two cases. J Neurosurg. 2001, 94:284-91.
• [36]Cohen ZR, Foumey DR, Marco RA, Rhines LD, Gokaslan ZL: Total cervical spondylectomy for primary osteogenic sarcoma, Case report and description of operative technique. J Neurosurg. 2002, 97(Suppl 3):386-92.
• [37]Clinical Musculoskeletal Pathology. 3rd edition. University of Florida Press, Gainesville, FL; 1990.
• [38]Chakravarti A, Spiro IJ, Hug EB, Mankin HJ, Efird JT, Suit HD: Megavoltage radiationtherapy for axial and inoperable giant cell tumor of bone. J Bone Joint Surg Am. 1999, 81:1566-73.
• [39]Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, et al.: Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013, 36:505-8.